MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Stock
Total 13F shares
990,152
Share change
+233,916
Total reported value
$1,053,750
Price per share
$1.07
Number of holders
35
Value change
+$247,784
Number of buys
10
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q4 2023

As of 31 Dec 2023, MiNK Therapeutics, Inc. - Stock (INKT) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 990,152 shares. The largest 10 holders included VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., CAPTRUST FINANCIAL ADVISORS, HighTower Advisors, LLC, CITADEL ADVISORS LLC, ORACLE INVESTMENT MANAGEMENT INC, and STATE STREET CORP. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.